AZIO AI Holdings confirmed its Atlas One campus in Texas is designed to operate entirely off the ERCOT grid, avoiding pending large-load interconnection requests amid Texas' new regulations on data centers. The state has imposed stricter rules requiring large energy users to cover their own infrastructure costs and undergo verification audits, responding to an overwhelming number of grid connection requests mostly from data centers. Atlas One generates its own power on-site using natural gas, reducing dependence on the grid and regulatory uncertainties. The project is progressing in phases, with a 10 MW hosting agreement signed but not yet energized, reflecting AZIO's strategy to build under tighter rules and maintain transparency with regulators and investors.
AZIO AI's Atlas One Texas AI Compute Campus is noted here with Pluang's Technology-sector market snapshot as of Nov 10, 2026 20:03 WIB: out of 150 US tech stocks, 40 rose and 101 fell. Among notable movers, QUBT dropped 5.98% to USD 6.45 with 98% sell orders, contrasting with IONQ at USD 33.30 down 5.77% but with a higher 30% buy order share, while AXTI fell 5.34% to USD 40.62 with a more balanced 57% sell and 43% buy activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
